COMPARE · Reviewed July 29, 2026
OTTR vs PAM
Verdict: Side-by-side breakdown using the Bull Rankings model. OTTR scored 41.5, PAM scored 53.2 — PAM leads.
Compare another set
OTTR
Otter Tail Corporation
41.5
$89.85 · $3.8B
fundamentals as of
Score gap
11.7
PAM leads
PAM
Pampa Energía S.A.
53.2
$89.02 · $4.8B
fundamentals as of
The model, pillar by pillar (0–100 each)
OTTR
stronger →← stronger
PAM
66
Qualityreturns · margins · balance sheet
58
22
Growthrevenue & earnings expansion
73
49
Valuevaluation vs sector peers
36
OTTR is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
OTTR
PAM
$2mC-
FCF
-$12mF
-0.5%D+
Rev
+8.3%B
0.63B
D/E
0.50B+
13.5xA
P/E
—
1.93C+
PEG
1.58C+
—
P/S
2.6xB
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
OTTR
PAM
17174% above
Price vs fair valuelower is cheaper
—
>60%/yr
Growth the price implies10-yr FCF · lower = less priced in
—
-99%
1-yr DCF upside
—
-99%
5-yr DCF upside
—
-100%
10-yr DCF upside
—
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
OTTR
Why this score
- Raising its dividend
PAM
No notable signals flagged.
The companies
OTTROtter Tail Corporation
Why now
Conglomerates · market cap $3.8b. 5% off the 52-week high of $95.00.
Moat
Net margin 21% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 15% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
PAMPampa Energía S.A.
Why now
Conglomerates · market cap $4.8b. 6% off the 52-week high of $94.50. 11 sell-side analysts rate this a Buy with a mean 1-yr target of $117.59 (implying +32% upside).
Moat
Net margin 33% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 19% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Free cash flow is negative (-$12m) — capital raises or debt issuance likely required; dilution / leverage risk.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.